CN110895264A - Method for determining ethyl bromide in tenofovir alafenamide - Google Patents
Method for determining ethyl bromide in tenofovir alafenamide Download PDFInfo
- Publication number
- CN110895264A CN110895264A CN201811059988.3A CN201811059988A CN110895264A CN 110895264 A CN110895264 A CN 110895264A CN 201811059988 A CN201811059988 A CN 201811059988A CN 110895264 A CN110895264 A CN 110895264A
- Authority
- CN
- China
- Prior art keywords
- tenofovir alafenamide
- bromoethane
- content
- determination
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
The invention provides a method for measuring ethyl bromide in tenofovir alafenamide, which adopts a solution direct injection method to measure, prepares tenofovir alafenamide into a certain solution, measures trace amount of ethyl bromide by using a capillary column taking 6% cyanopropylphenyl-94% dimethylpolysiloxane as a stationary liquid, and calculates the content of ethyl bromide in tenofovir alafenamide by an external standard method. The method only needs to use a proper solvent to prepare the tenofovir alafenamide into a solution, has simple pretreatment and easy operation, and can better determine the content of ethyl bromide in the tenofovir alafenamide.
Description
Technical Field
The invention belongs to the field of pharmaceutical analysis, and particularly designs a method for determining ethyl bromide in tenofovir alafenamide.
Background
The synthesis route of tenofovir alafenamide may generate a bromoethane by-product in the reaction process. 27/10/2017, published by international cancer research institute of world health organization, "precancerous list preliminary reference", bromoethane belongs to 3 kinds of carcinogenic substances. A plurality of literature reports exist in China for measuring the bromoethane, but the measurement of the bromoethane in tenofovir alafenamide is rarely reported in China at present, and the measurement is occasionally reported, the method is complex, and the sensitivity and the accuracy are not high.
Bromoethane is a colorless oily liquid with an ether-like odor and a burning odor. It turns yellow gradually when exposed to air or light, is easy to volatilize, can be mixed and dissolved with ethanol, diethyl ether, trichloromethane and most organic solvents, and has a boiling point of 38.4 ℃.
Disclosure of Invention
[1] The invention provides a method for determining ethyl bromide in tenofovir alafenamide, which has the advantages of simple operation, high sensitivity, high accuracy and the like.
[2] The specific technical scheme of the invention is as follows:
(1) the tenofovir alafenamide is formulated into a solution with a suitable solvent.
(2) Directly injecting sample, measuring by capillary gas chromatography, and calculating bromoethane content by external standard method, wherein the gas chromatography conditions are as follows: a capillary column using 6% cyanopropylphenyl-94% dimethylpolysiloxane as a stationary liquid is heated to 220 ℃ at the initial temperature of 35-45 ℃ at the rate of 30 ℃/min per minute and is maintained for 5-8 minutes; the temperature of the detector is 250 ℃; the temperature of the sample inlet is 150-220 ℃, the split ratio is 2: 1-5: 1, and the flow rate of the column is 2-4 ml/min.
[3] Detailed description of the preferred embodiments
The following examples are provided to illustrate specific steps of the present invention, but are not intended to limit the present invention. The invention is described in further detail below with reference to specific examples and data, it being understood that these examples are intended to illustrate the invention and are not intended to limit the scope of the invention in any way.
(1) Selection of solvents
The tenofovir alafenamide is dissolved in organic solvents such as methanol, acetonitrile, acetone and dimethylformamide. Because the limit of ethyl bromide is lower, tenofovir alafenamide needs to be dissolved as much as possible, and methanol, acetonitrile, acetone and dimethylformamide can be selected as solvents according to the solubility information of the tenofovir alafenamide. Dimethylformamide has a boiling point of 152.8 ℃ and the difference between the boiling points of dimethylformamide and bromoethane is large, and dimethylformamide is preferably used as a solvent.
(2) Selection of chromatographic conditions
A capillary column using 6% cyanopropylphenyl-94% dimethylpolysiloxane as a stationary liquid is heated to 220 ℃ at the initial temperature of 35-50 ℃ at the rate of 30 ℃/min per minute and is maintained for 5-8 minutes; the temperature of the detector is 250 ℃; the temperature of a sample inlet is 150-220 ℃, the split ratio is 2: 1-5: 1, the flow rate of the column is 2-4 ml/min, and the flow rate of the carrier gas is 1.5-3 ml/min.
Influence of the onset temperature: the initial temperature is preferably 35 ℃ in consideration of the influence of the peak height, the degree of separation, the peak pattern and the number of theoretical plates due to the change in the column temperature.
Influence of Carrier gas flow: in order to obtain better separation determination effect, the method preferably has carrier gas flow of 2ml/min
Influence of split ratio: in order to better achieve the separation effect of each peak and ensure the detection sensitivity, the split ratio is preferably 3: 1.
Influence of equilibration time: the length of the equilibration time affects the diffusion rate of the molecules of the component being measured from the sample matrix to the gas phase. The samples are balanced for 5-8 minutes at 35-50 ℃, and the sample injection is inspected, so that the temperature is overhigh, the balance time is overlong, and the separation degree is good, therefore, the balance time is preferably 5 minutes at 35 ℃.
(3) The method of the invention is used for determining the content of ethyl bromide in tenofovir alafenamide
Standard curve test: an appropriate amount of bromoethane was weighed out precisely, dissolved in dimethylformamide and diluted to a solution containing about 10.62. mu.g per 1ml, and shaken up. Precisely measuring 0.2 ml, 0.5ml, 1.0 ml, 4.0 ml, 6.0 ml and 8.0ml of bromoethane stock solution respectively, placing the bromoethane stock solution into a 20ml measuring flask respectively, diluting the bromoethane stock solution to a scale by using dimethylformamide, and shaking up the bromoethane stock solution to obtain linear relation test solution; and precisely measuring 1 mu l of each linear relation test solution respectively, injecting the linear relation test solution into a gas chromatograph, and recording the chromatogram. Linear regression was performed with the concentration of bromoethane as abscissa x and the peak area of bromoethane as ordinate y to find the linear equation y =0.0329x +0.0053, R2=0.9954, the linear relationship was good, and the results are shown in table 1 and fig. 1.
TABLE 1 Linear relationship test
Precision analysis: dissolving and diluting dimethylformamide to prepare a reference substance solution containing 0.531 mug per 1ml, precisely measuring 1 mug, injecting into a gas chromatograph, recording a chromatogram, continuously injecting samples for 6 times, wherein the RSD of the peak area of the reference substance is 7.65%, the RSD of the retention time is 0.12%, the precision of the instrument is good, the separation degree of bromoethane in each reference substance solution is more than 1.5, the separation is complete, the number of theoretical plates is more than 10000, and the peak pattern is good. The results are shown in Table 2.
TABLE 2 precision test
Sample introduction sequence number | 1 | 2 | 3 | 4 | 5 | 6 | Average | RSD% |
Peak area | 0.024 | 0.022 | 0.027 | 0.026 | 0.023 | 0.024 | 0.024 | 7.65 |
Degree of separation | 2.47 | 2.3 | 2.31 | 2.49 | 2.27 | 2.17 | / | / |
Number of theoretical plates | 32854 | 26797 | 22604 | 26572 | 27030 | 25413 | / | / |
Recovery rate test: a spiking recovery test was used. : 1g of sample is taken and precisely weighed, the sample is placed into a 10ml measuring flask, 0.5ml of bromoethane stock solution is added, the solution is dissolved and diluted to the scale by dimethylformamide, and the mixture is shaken up to 6 parts in total. The measured amount of the bromoethane is calculated by the peak area according to an external standard method, the calculated recovery rate is 97.95-112.65%, the RSD is 5.30%, and the result is shown in Table 3, which shows that the method has high accuracy in measuring the bromoethane.
TABLE 3 recovery test
Description of the drawings:
FIG. 1 is a graph of linear relationship and range experiments.
Claims (6)
1. A method for determining ethyl bromide in tenofovir alafenamide is characterized by being carried out in the following mode:
chromatographic conditions are as follows: a capillary column using 6% cyanopropylphenyl-94% dimethylpolysiloxane as a stationary liquid is heated to 220 ℃ at the initial temperature of 35-45 ℃ at the rate of 30 ℃/min per minute and is maintained for 5-8 minutes; the temperature of the detector is 250 ℃; the temperature of a sample inlet is 150-220 ℃, the split ratio is 2: 1-5: 1, the flow rate of a column is 2-4 ml/min, and the preparation of a sample solution: preparing a tenofovir alafenamide solution by using an organic solvent, wherein the selected solvent comprises methanol, ethanol, acetonitrile, acetone and dimethylformamide as a solvent, and measuring: and (3) directly injecting the solution into a gas chromatograph, recording a chromatogram, and analyzing, wherein the separation degree is more than 1.5, and the number of theoretical plates is not less than 5000.
2. The determination of the bromoethane content of tenofovir alafenamide by gas chromatography according to claim 1, characterized in that the carrier gas flow rate is 2 ml/min.
3. The determination of the bromoethane content of tenofovir alafenamide by gas chromatography according to claim 1, characterized by an onset temperature of 35 ℃.
4. The determination of the bromoethane content of tenofovir alafenamide by gas chromatography according to claim 1, characterized in that the sample solution is formulated to contain tenofovir alafenamide 0.1 g/ml.
5. The determination of the bromoethane content of tenofovir alafenamide by gas chromatography according to claim 1, characterized by a split stream of 3: 1.
6. The determination of the bromoethane content of tenofovir alafenamide by gas chromatography according to claim 1, characterized by equilibration at 35 ℃ for 5 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811059988.3A CN110895264A (en) | 2018-09-12 | 2018-09-12 | Method for determining ethyl bromide in tenofovir alafenamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811059988.3A CN110895264A (en) | 2018-09-12 | 2018-09-12 | Method for determining ethyl bromide in tenofovir alafenamide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110895264A true CN110895264A (en) | 2020-03-20 |
Family
ID=69784978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811059988.3A Pending CN110895264A (en) | 2018-09-12 | 2018-09-12 | Method for determining ethyl bromide in tenofovir alafenamide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110895264A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113295791A (en) * | 2021-05-21 | 2021-08-24 | 珠海联邦制药股份有限公司 | Method for analyzing ethyl bromide in sulbactam sodium |
CN113514564A (en) * | 2020-04-10 | 2021-10-19 | 昆药集团股份有限公司 | Method for detecting residues 1, 2-dibromoethane and 1, 3-dibromopropane in homopiperazine |
-
2018
- 2018-09-12 CN CN201811059988.3A patent/CN110895264A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113514564A (en) * | 2020-04-10 | 2021-10-19 | 昆药集团股份有限公司 | Method for detecting residues 1, 2-dibromoethane and 1, 3-dibromopropane in homopiperazine |
CN113295791A (en) * | 2021-05-21 | 2021-08-24 | 珠海联邦制药股份有限公司 | Method for analyzing ethyl bromide in sulbactam sodium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105067728A (en) | Method for measuring solvent compositions in nicotine liquid by combining gas chromatography and mass spectrometry | |
CN113466353A (en) | Method for detecting 6-chloro-2-hexanone related substances | |
CN110895264A (en) | Method for determining ethyl bromide in tenofovir alafenamide | |
CN111272900B (en) | Gas chromatography analysis method for detecting content of 3-chloro-2, 2-dimethyl-1-propanol | |
CN110220989B (en) | Method for detecting fasudil hydrochloride and 9 related substances thereof | |
CN101581708B (en) | Method for measuring low-concentration methylcyclopentadienyl manganese tricarbonyl by gas chromatography internal standard method | |
CN114217002B (en) | Method for detecting contents of chamomile azulene and sabinene in chamomile essential oil | |
CN105758970B (en) | A kind of method of gas chromatography detection 3- methylamino -1,2- propane diols purities | |
CN108872416A (en) | A kind of method of simultaneous quantitative detection erucyl amide and ethylene bis stearamide | |
CN111426760B (en) | Method for determining genotoxic impurities in doxofylline raw material medicine | |
CN110376302B (en) | Method for detecting m-fluorobenzaldehyde and m-fluorobenzene cinnamaldehyde | |
CN109738555B (en) | Method for measuring content of orthoformate in crude orthoformate | |
CN115128177A (en) | Method for analyzing and determining genotoxic impurities in ganciclovir condensation compound by using HPLC method | |
CN106124642A (en) | A kind of green tea determination of acrylamide and application | |
CN112305100B (en) | Method for detecting content of genotoxic impurity benzyl bromide in medicine | |
CN105974017B (en) | The assay method of methanol content in flavouring essence for tobacco | |
CN116381075B (en) | GC-MS (gas chromatography-mass spectrometry) -based method for detecting C0 in D5 | |
CN114200067B (en) | High performance liquid chromatography analysis method for 6-bromo-3-hydroxy pyrazine-2-carboxamide and impurities | |
CN112730642B (en) | Method for simultaneously detecting methyl trifluoromethanesulfonate and ethyl trifluoromethanesulfonate in tubulin inhibitor bulk drug | |
CN113777204B (en) | Detection method of p-hydroxyacetophenone related substances | |
CN116930368B (en) | Detection method of settop alcohol isomer | |
CN116879428B (en) | High performance liquid analysis method for residual content of phosphorylcholine in L-alpha-phosphorylcholine | |
CN106018595A (en) | Method for detecting purity of 3-methylamino-1,2-propylene glycol with capillary column method | |
CN102288699B (en) | Method for measuring acetic anhydride and pyridine in reaction liquid with gas phase chromatography internal standard method | |
CN109507327B (en) | Quantitative determination of TNT content by GC-AED independent calibration curve method (CIC method) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200320 |
|
WD01 | Invention patent application deemed withdrawn after publication |